Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[The value of genetics in the era of hepatitis C triple therapy].

Gastroenterologia y hepatologia - 1 Jan 2000

Quiles-Pérez Rosa, Pavón-Castillero Esther José, Muñoz-de-Rueda Paloma, Carmona Isabel, Salmerón Javier

Abstract excerpt

Despite the introduction of protease inhibitors (PI) in the treatment of hepatitis C, the sensitivity of interferon continues to be essential to achieve a sustained virological response (SVR) and to eradicate the viral infection. Currently, pegylated interferon (PEG-IFN) and ribavirin (RBV) are required to avoid selection of PI-resistance mutations. The likelihood of obtaining an SVR with dual therapy in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia
Share to Antiviral Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to IFNL3 gene

Share to Genotype

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Treatment Outcome

Source

Identifiers

PMID: 24948442
DOI: 10.1016/j.gastrohep.2014.04.004

Genes

IFNL3
ITPA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[The value of genetics in the era of hepatitis C triple therapy].PMID 24948442Read ↗

[Significance of hepatitis C virus baseline polymorphism during the antiviral therapy].Semantic proximity Read ↗

[Genetic diagnosis of hepatitis C virus infection].Semantic proximity Read ↗

Genomic determinants of hepatitis C virus antiviral therapy outcomes: toward individualized treatment.Semantic proximity Read ↗

Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C.Semantic proximity Read ↗

[Virus factors determining the outcome of IFN treatment for chronic hepatitis C].Semantic proximity Read ↗

The role of viral and host genetics in natural history and treatment of chronic HCV infection.Semantic proximity Read ↗

[Genetic mutation of hepatitis C virus and host's immune response].Semantic proximity Read ↗

[Genetic polymorphisms as new predictive factors for successful treatment of chronic hepatitis C].Semantic proximity Read ↗

[Genetic variability of the hepatitis C virus: clinical implications].Semantic proximity Read ↗

[Mechanism of hepatitis C virus (HCV) RNA replication and HCV genetic variability].Semantic proximity Read ↗

[Hepatitis B and C virus antiviral resistance].Semantic proximity Read ↗

Redefining baseline demographics: the role of genetic testing in hepatitis C virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.